z-logo
Premium
Antiarrhythmic action of rilmenidine on adrenaline‐induced arrhythmia via central imidazoline receptors in halothane‐anaesthetized dogs
Author(s) -
Mammoto Tadanori,
Kamibayashi Takahiko,
Hayashi Yukio,
Yamatodani Atsushi,
Takada Koji,
Yoshiya Ikuto
Publication year - 1996
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1996.tb15348.x
Subject(s) - rilmenidine , imidazoline receptor , idazoxan , chemistry , pharmacology , rauwolscine , halothane , medicine , prazosin , endocrinology , agonist , antagonist , receptor , organic chemistry
1 To elucidate the role of central imidazoline receptors in the genesis of adrenaline‐induced arrhythmias under halothane anaesthesia, we investigated the effects of rilmenidine, a selective agonist at imidazoline receptors, on this type of arrhythmia in dogs. Rilmenidine (1, 3, 10 μg kg −1 , i.v.) did not affect basal haemodynamic parameters (heart rate and blood pressure), but dose‐dependently inhibited adrenaline‐induced arrhythmias under halothane anaesthesia. 2 Although, rilmenidine has a weak affinity for α 2 ‐adrenoceptors, pretreatment with idazoxan (10 μg kg −1 , intracistenally i.c.), an imidazoline receptor antagonist which has also α 2 ‐adrenoceptor blocking potency, blocked the antiarrhythmic effect of rilmenidine (10 μg kg −1 , i.v.). In contrast, pretreatment with rauwolscine (20 μg kg −1 , i.c.), a classical α 2 ‐adrenoceptor antagonist with little affinity for imidazoline receptors, did not affect the effect of rilmenidine (10 μg kg −1 , i.v.). Furthermore, bilateral vagotomy completely blocked the antiarrhythmic action of rilmenidine (10 μg kg −1 , i.v.). 3 It is suggested that the antiarrhythmic action of rilmenidine is due to the activation of central imidazoline receptors and that vagal tone is critical for this action of rilmenidine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here